What is a Wegovy maintenance dose?

When patients first start Wegovy (semaglutide 2.4 mg), the journey begins with a carefully structured dose-escalation schedule. The goal is not to stay at a low dose forever, but to reach a level where the medication effectively controls appetite and supports sustained weight loss without overwhelming side effects. That stable, long-term dose is what clinicians call the Wegovy maintenance dose . In simple terms, it is the dose you remain on once you and your healthcare provider have agreed that your weight has stabilized and your body has adjusted to the medication.

Understanding the maintenance dose matters because is not a short-term intervention for most people. Obesity is a chronic condition, and stopping treatment often leads to weight regain. The maintenance phase is therefore the heart of successful therapy. During this phase, the dose is no longer being increased every four weeks. Instead, it becomes a steady anchor that helps you preserve the progress you have made.

The standard escalation for Wegovy typically follows this pattern: 0.25 mg weekly for four weeks, then 0.5 mg, 1 mg, 1.7 mg, and finally 2.4 mg. Each step lasts at least four weeks. The maintenance dose is usually the highest dose a patient can tolerate while still achieving good results. However, it is not always 2.4 mg. Some patients do very well at 1.7 mg, and a smaller number may need to stay at 1 mg if higher doses cause intolerable nausea or other side effects.

What makes the maintenance concept unique is its individualized nature. Two patients of the same weight and height may end up on different maintenance doses. Factors such as gastrointestinal sensitivity, other medications, kidney function, and even personal weight-loss goals all play a role. In Hong Kong, where obesity rates have been rising—around 30% of adults are classified as obese according to the Department of Health—long-term strategies like maintenance dosing are increasingly relevant. The key takeaway is that the maintenance dose is not a race to the highest number. It is a personalized, sustainable level that balances efficacy, tolerability, and long-term adherence.

How to know when you have reached your maintenance dose

Knowing when you have reached your maintenance dose is less about a specific number on the scale and more about a combination of clinical judgment and how you feel. In most cases, your healthcare provider will determine that you are at maintenance when your weight has plateaued for several weeks, your appetite is consistently well controlled, and you are not experiencing significant side effects that interfere with daily life. This usually happens after you have completed the full titration schedule, but it can also occur earlier if you and your doctor decide that a lower dose is already giving you excellent results.

From a clinical perspective, there are several signs that you have reached maintenance. First, your weight loss has slowed to a predictable, gentle rate—or has stopped altogether while you continue healthy habits. Second, you are not constantly thinking about food. Third, you can eat normal meals without feeling overly full or nauseated. Fourth, your blood sugar and other metabolic markers, if relevant, are stable. Fifth, you have been on the same dose for at least four to eight weeks without needing to change it.

Patients often ask whether they should aim for a specific maintenance dose like 2.4 mg because that is the dose used in major clinical trials. The answer is no. The STEP trials showed that 2.4 mg produces average weight loss of about 15%, but many participants in those trials could not tolerate that dose. In real-world practice, including in Hong Kong, clinicians often settle on 1.7 mg or 1 mg as the maintenance dose. A 2023 survey of obesity specialists in Asia found that nearly 40% of patients were maintained on doses below 2.4 mg.

It is also important to distinguish between reaching a maintenance dose and reaching a goal weight. Some patients reach their goal weight at 1.7 mg and then stay there. Others reach 2.4 mg but still have more weight to lose, so they remain at 2.4 mg as their maintenance dose while continuing lifestyle changes. The maintenance dose is simply the dose you stay on for the long term. Your provider will confirm this through regular check-ins, typically every 4 to 12 weeks during the first year, and then less frequently once stable.

One practical tip: keep a simple log of your weekly weight, appetite level, and any side effects. This record helps your provider see patterns and make an informed decision about when you have truly reached maintenance. Without such data, it is easy to mistake a temporary plateau for a true maintenance state.

The recommended maintenance dose range for most patients

While the official label for Wegovy lists 2.4 mg as the target maintenance dose, real-world evidence shows that the effective maintenance range is broader. Most patients end up somewhere between 1.7 mg and 2.4 mg per week. A smaller but significant group remains on 1 mg, and a very small number stay on 0.5 mg if they are highly sensitive to the medication or have other medical considerations. The table below summarizes typical maintenance doses based on clinical experience and published data.

Maintenance Dose	Approximate Proportion of Patients	Typical Characteristics
0.5 mg weekly	5–10%	Very sensitive to side effects; still achieves modest weight loss
1 mg weekly	15–20%	Good tolerability; steady weight loss of 5–10%
1.7 mg weekly	30–40%	Most common real-world maintenance dose; strong appetite control
2.4 mg weekly	30–40%	Highest efficacy but also highest rate of nausea and vomiting

It is worth noting that these percentages vary by region and patient population. In Hong Kong, where many patients are started on Wegovy through private endocrinology or weight-management clinics, physicians often adopt a more conservative approach. A 2024 local audit of 150 patients found that 1.7 mg was the most frequently prescribed maintenance dose, with only 28% reaching 2.4 mg. The reasons included cost, side effect tolerance, and patient preference for a gentler experience.

The recommended range is therefore not a single number but a spectrum. For most patients, the sweet spot is the lowest dose that keeps hunger and cravings under control while allowing a healthy, gradual weight loss or weight maintenance. Higher is not always better. In fact, staying at a lower maintenance dose can reduce the risk of long-term side effects and make the medication more affordable, which is a major consideration for many people in Hong Kong who pay out of pocket.

Your provider will typically start you at the lowest effective dose and only increase if your weight loss stalls and you are tolerating the current dose well. Once you reach a dose where your weight is stable and your appetite is managed, that becomes your maintenance dose. It is perfectly acceptable to remain at 1.7 mg indefinitely if it works for you.

What happens if you stop taking Wegovy at maintenance

One of the most common questions about wegovy use is what happens when you stop. The short answer is that weight regain is very likely. Clinical trials and real-world studies consistently show that within one year of stopping semaglutide, patients regain about two-thirds of the weight they lost. This is not a failure of willpower; it is a biological response. The medication suppresses appetite and slows gastric emptying. When it is removed, hunger returns, often stronger than before, and metabolism may remain slightly lower than before weight loss.

The STEP 1 extension trial found that participants who stopped Wegovy after 68 weeks regained 11.6% of their body weight within the following year, compared with a continued loss in those who stayed on the medication. A similar pattern has been observed in Hong Kong patients. A local weight-management center reported that among 80 patients who discontinued Wegovy after reaching maintenance, 70% regained at least half of their lost weight within 18 months. Only 20% maintained their weight loss, and these individuals tended to have continued intensive lifestyle support.

Stopping at maintenance also has metabolic consequences. Blood pressure, blood sugar, and cholesterol improvements tend to revert toward baseline. For patients who had prediabetes or type 2 diabetes, stopping can lead to worsening glycemic control. This is why most guidelines, including those from the Hong Kong Association for the Study of Obesity, recommend that Wegovy be considered a long-term therapy, similar to blood pressure or cholesterol medication.

That said, some patients do stop successfully. They are usually those who have built very strong exercise and dietary habits, who continue regular monitoring, and who accept that they may need to restart the medication if weight regain occurs. If you are considering stopping, do not do so abruptly without talking to your provider. A gradual taper—reducing the dose over several weeks or months—may help ease the transition, although evidence for tapering is still limited. Some clinicians recommend switching to a lower maintenance dose rather than stopping completely.

The key message is that stopping Wegovy at maintenance is a decision with significant consequences. It should be made with your healthcare team, and you should have a clear plan for monitoring your weight, appetite, and metabolic health afterward.

Strategies for staying on track with your maintenance dose

Reaching your maintenance dose is a milestone, but staying on track requires ongoing effort. The medication makes it easier, but it does not do all the work. The most successful patients combine their maintenance dose with structured lifestyle strategies. Two areas deserve special attention: managing hunger and cravings, and combining diet and exercise.

Managing hunger and cravings

Even at an effective maintenance dose, hunger and cravings can break through, especially around mealtimes, during stress, or when you are exposed to high-calorie food cues. The first step is to recognize that these feelings are normal and not a sign that the medication has stopped working. The second step is to have a plan.

• Eat protein first. Protein is the most satiating macronutrient. Aim for 25–30 grams per meal. In Hong Kong, good sources include steamed fish, tofu, eggs, and lean chicken.
• Fill up on fiber. Vegetables, legumes, and whole grains slow digestion and stabilize blood sugar. A bowl of vegetable soup before meals can reduce overall intake.
• Stay hydrated. Thirst is often mistaken for hunger. Keep a water bottle with you and sip throughout the day.
• Plan for cravings. If you know you crave something sweet after dinner, have a small portion of fruit or a sugar-free jelly ready. Deprivation leads to binges.
• Use distraction. When a craving hits, wait 10 minutes and do something else—walk, call a friend, or brush your teeth. Cravings often pass.

If hunger becomes persistent despite these strategies, talk to your provider. Sometimes a small increase in dose is needed, or a change in injection timing. Do not suffer in silence.

Combining diet and exercise

Exercise is not just for burning calories. It helps preserve muscle mass, which is important because rapid weight loss can lead to muscle loss. Muscle loss slows metabolism and makes weight regain more likely. Resistance training at least twice a week is ideal. This can be done at home with bands or bodyweight exercises, or at a gym. Walking, swimming, and cycling are also excellent.

Diet-wise, the Mediterranean-style eating pattern has the best evidence for long-term weight maintenance. It emphasizes vegetables, fruits, whole grains, olive oil, fish, and nuts, with limited red meat and processed foods. In Hong Kong, this can be adapted to local cuisine: choose steamed over fried, brown rice over white, and fresh fruit over dessert.

Tracking your food and exercise for a few weeks can raise awareness, but you do not need to do it forever. The goal is to build habits that feel automatic. Many patients find that after 6–12 months on a maintenance dose, healthy choices become easier because the medication reduces the reward value of junk food. Use that window to cement your new lifestyle.

Can your maintenance dose be lowered over time?

Yes, in some cases the maintenance dose can be lowered over time. This is not common in the first year, but it becomes more feasible after you have maintained your weight loss for 12–18 months. The rationale is that your body may become more sensitive to the medication, or you may have built enough lifestyle habits to maintain your weight with less pharmacological support. Lowering the dose can reduce side effects and cost.

A typical scenario: a patient reaches 1.7 mg, loses 12% of body weight, and remains stable for a year. They then work with their doctor to step down to 1 mg. If weight remains stable for another 3–6 months, they may try 0.5 mg. Some patients eventually transition to a lower dose or even off the medication entirely, but this is the exception rather than the rule.

It is important not to lower the dose too quickly. The STEP 4 trial showed that patients who were switched to placebo after 20 weeks of maintenance regained significant weight compared with those who stayed on 2.4 mg. A gradual, monitored reduction is safer. In Hong Kong, some private clinics offer a structured “dose de-escalation” program with monthly check-ins. This is not yet standard in public hospitals, but it is gaining interest.

If you want to lower your maintenance dose, discuss it with your provider. They will likely ask you to keep a detailed log of weight, appetite, and side effects. If you notice weight gain of more than 2–3 kg or a return of strong cravings, you may need to go back up. There is no shame in that—it simply means your body still needs the support.

Side effects at the maintenance dose and how to handle them

Side effects do not disappear once you reach maintenance. Some patients actually notice them more because they are no longer distracted by the novelty of starting treatment. The most common side effects at maintenance are nausea, vomiting, diarrhea, constipation, and fatigue. These are usually mild and improve with time, but they can be persistent for a minority.

Nausea is the most frequent complaint. It often occurs after eating too quickly or eating greasy food. To manage it, eat smaller meals, chew slowly, and avoid high-fat foods. Ginger tea or peppermint can help. If nausea is severe, your provider may prescribe an antiemetic or lower your dose.

Constipation is also common because semaglutide slows gut motility. Increase fiber and water intake, and consider a stool softener if needed. Diarrhea can occur too, especially if you eat large amounts of sugar alcohols or fatty foods. Keeping a food diary can help identify triggers.

More serious but rare side effects include pancreatitis, gallbladder disease, and kidney problems. Seek immediate medical attention if you have severe abdominal pain, persistent vomiting, or signs of dehydration. In Hong Kong, the Hospital Authority has issued guidance that patients on GLP-1 receptor agonists should be monitored for these complications, especially during the first six months.

Fatigue is often due to inadequate calorie or protein intake. Make sure you are eating enough. Some patients also experience injection-site reactions, which can be minimized by rotating injection sites and allowing the pen to reach room temperature before use.

If side effects are interfering with your daily life, do not stop the medication on your own. Contact your provider. They may adjust the dose, change the injection day, or add a medication to help. Most side effects are manageable with the right support.

Cost and insurance considerations for long-term Wegovy use

Cost is a major barrier to long-term wegovy use , especially in places where the medication is not publicly funded. In Hong Kong, Wegovy is not covered by the Hospital Authority for obesity alone, although it may be prescribed for type 2 diabetes under certain conditions. Most patients pay out of pocket at private clinics or pharmacies. The monthly cost can range from HK$3,000 to HK$6,000, depending on the dose and pharmacy.

Insurance coverage varies. Some private health insurance plans in Hong Kong cover weight-loss medications if prescribed by a specialist and if the patient has a BMI above a certain threshold, often 30 or 27 with comorbidities. However, many plans exclude obesity treatment entirely. It is essential to check your policy carefully before starting.

For those paying out of pocket, there are ways to reduce costs. First, consider a lower maintenance dose if it works for you—1.7 mg is cheaper than 2.4 mg. Second, ask about bulk purchasing or manufacturer coupons. Third, some clinics offer package deals that include consultations and medication. Fourth, if you have a flexible spending account or health savings account, you may be able to use pre-tax dollars.

Consideration	Typical Situation in Hong Kong
Public hospital coverage	Not routinely covered for obesity
Private insurance	Variable; often requires specialist and BMI criteria
Out-of-pocket cost	HK$3,000–6,000 per month
Cost-saving strategies	Lower maintenance dose, bulk buying, clinic packages

Long-term cost also includes monitoring visits, blood tests, and potential management of side effects. These add to the total. It is wise to budget for at least one year of treatment, as weight regain is likely if you stop early. Some patients find that the cost of Wegovy is offset by reduced spending on takeout food, sugary drinks, and medications for obesity-related conditions like hypertension and diabetes.

If cost is prohibitive, talk to your provider about alternatives. Other GLP-1 medications may be cheaper, and some lifestyle programs can be effective, though typically less so than medication. Do not let cost lead you to skip doses or share medication—this is dangerous and can lead to relapse.

Long-term success with the right maintenance dose

Long-term success with Wegovy is not about finding a magic number. It is about finding the right maintenance dose for your body, your lifestyle, and your budget, and then supporting that dose with sustainable habits. The patients who do best are those who view obesity as a chronic condition, just like high blood pressure or high cholesterol. They take their medication regularly, keep their appointments, and adapt their diet and exercise as needed.

In Hong Kong, the landscape of obesity care is changing. More clinics are offering comprehensive programs that combine medication, nutrition counseling, and psychological support. The key is to stay engaged. Regular monitoring—at least every three months during the first year—allows for timely adjustments. If you notice weight regain or worsening side effects, speak up early.

Remember that the maintenance dose is a tool, not a punishment. It should make your life easier, not harder. If you are struggling, your provider can help you find a better fit. Do not compare your dose to someone else’s. What matters is that you are maintaining your weight loss, feeling well, and reducing your risk of obesity-related diseases.

Finally, celebrate your progress. Keeping weight off for a year, two years, or five years is a significant achievement. With the right maintenance dose and a supportive team, it is absolutely possible. Stay consistent, stay curious, and stay in touch with your healthcare provider. Your long-term health is worth the effort.